It is a link for moving within the page.

Go to the main.
Go to the global navigation.
Go to navigation by category.
Go to the footer.

News Releases

RSS

26 MAR 2020Pharmaceuticals: Development of the first comprehensive genomic profiling assay for hematologic malignancies in Japan- Consortium of major Japanese hospitals and Otsuka Pharmaceutical start a project to evaluate its clinical utility -

26 MAR 2020Pharmaceuticals: Otsuka Announces Top-line Results from Two Phase 3 Studies in Japan for Atopic Dermatitis Drug Candidate Difamilast (OPA-15406)

25 MAR 2020Pharmaceuticals: Cabpirin_® Combination Tablet Receives Regulatory Approval in Japan for Treatment of Acid-related Diseases in Patients Needing Low-dose Aspirin

25 MAR 2020Pharmaceuticals: Otsuka's Busulfex Receives Additional Indication in Japan as a Conditioning regimen Prior to Autologous Hematopoietic Stem Cell Transplantation for Malignant Lymphoma

16 MAR 2020Nutraceuticals: Dietary Education App "SketchCook"
Recognized with Ministry of Education, Culture, Sports, Science and Technology（MEXT）
"Award for Companies Promoting Experience-based Learning Activities for Youth 2019"

13 MAR 2020Nutraceuticals: Newly published findings on inhibitory effect of near-infrared (IRA) radiation on human epidermal cell proliferation and potential mechanisms

10 MAR 2020Corporate: Otsuka Pharmaceutical Reappointments and New Appointments of Board Members and Statutory Auditors (PDF:57.4 KB)

3 MAR 2020Nutraceuticals: Introducing InnerSignal Rejuvenate ONE－All-in-One Skin Care Product with Time-Lapse Penetration Combines Lightening and Three Basic Skin Care Functions－

2 MAR 2020Pharmaceuticals: Otsuka enters into co-promotion agreement for angiotensin receptor neprilysin inhibitor (ARNI) LCZ696 in Japan

27 FEB 2020Pharmaceuticals: First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis

RSS